Scopus BioPharma Inc. — key financial figures for fiscal year 2022 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2022)
- $0
- Net Income/Loss (FY2022)
- -$11.7M
- Total Assets (FY2022)
- $392.3K
- Total Equity (FY2022)
- -$7.1M
- Cash Flows from Operating Activities (FY2022)
- -$8.1M
Source: Scopus BioPharma Inc. 10-K filing (FY2022). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
